In this study, we test the hypothesis that impairment of SCL activity in patients with mitochondrial disease due to mutations in SUCLA2 leads to increased levels of succinyl-CoA as a donor for succinylation reactions. This evidence concerns the gene SUCLA2 and inborn mitochondrial metabolism disorder.